Barnett, Michael H.

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet

Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling

Cited by 942

Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis

Ramanathan, S., Prelog, K., Barnes, E. H., Tantsis, E. M., Reddel, S. W., Henderson, A. P., Vucic, S., Gorman, M. P., Benson, L. A., Alper, G., et al. (2016) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesOcular Diseases and Behçet’s Syndrome

Cited by 384

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

Ribbons, K. A., McElduff, P., Boz, C., Trojano, M., Izquierdo, G., Duquette, P., Girard, M., Grand’Maison, F., Hupperts, R., Grammond, P., et al. (2015) · PLOS ONE

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 190

Atypical inflammatory demyelinating syndromes of the CNS

Hardy, T. A., Reddel, S. W., Barnett, M. H., Palace, J., Lucchinetti, C. F., & Weinshenker, B. G. (2016) · The Lancet Neurology

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 161

The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases

Garg, N., Reddel, S. W., Miller, D. H., Chataway, J., Riminton, D. S., Barnett, Y., Masters, L., Barnett, M. H., & Hardy, T. A. (2015) · Journal of Neurology, Neurosurgery & Psychiatry

Multiple Sclerosis Research StudiesReceptor Mechanisms and Signaling

Cited by 76

Decoding Diffusivity in Multiple Sclerosis: Analysis of Optic Radiation Lesional and Non-Lesional White Matter

Klistorner, A., Vootakuru, N., Wang, C., Yiannikas, C., Graham, S. L., Parratt, J., Garrick, R., Levin, N., Masters, L., Lagopoulos, J., et al. (2015) · PLOS ONE

Advanced Neuroimaging Techniques and ApplicationsMultiple Sclerosis Research Studies

Cited by 59

Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS

Lorscheider, J., Jokubaitis, V. G., Spelman, T., Izquierdo, G., Lugaresi, A., Havrdova, E., Horakova, D., Trojano, M., Duquette, P., Girard, M., et al. (2017) · Neurology

Multiple Sclerosis Research StudiesChronic Lymphocytic Leukemia Research

Cited by 44

Diagnosis, Differential Diagnosis and Misdiagnosis of Susac Syndrome

Triplett, J. D., Qiu, J., O'Brien, B., Gopinath, S., Trewin, B., Spring, P. J., Shaffi, M., Ip, J., Chan, F., Chen, L., et al. (2022) · European Journal of Neurology

Ocular Diseases and Behçet’s SyndromeRetinal and Optic Conditions

Cited by 41

A randomized controlled trial of a web-based mindfulness programme for people with MS with and without a history of recurrent depression

Sesel, A.-L., Sharpe, L., Beadnall, H. N., Barnett, M. H., Szabo, M., & Naismith, S. L. (2022) · Multiple Sclerosis Journal

Mindfulness and Compassion InterventionsDigital Mental Health Interventions

Cited by 22

Diffusivity in the core of chronic multiple sclerosis lesions

Klistorner, A., Wang, C., Yiannikas, C., Parratt, J., Barton, J., You, Y., Graham, S. L., & Barnett, M. H. (2018) · PLOS ONE

Advanced Neuroimaging Techniques and ApplicationsMultiple Sclerosis Research Studies

Cited by 11

Differentiating axonal loss and demyelination in chronic MS lesions: A novel approach using single streamline diffusivity analysis

Klistorner, S., Barnett, M. H., Wasserthal, J., Yiannikas, C., Barton, J., Parratt, J., You, Y., Graham, S. L., & Klistorner, A. (2021) · PLOS ONE

Advanced Neuroimaging Techniques and ApplicationsMultiple Sclerosis Research Studies

Cited by 10